Cancer in India is still diagnosed predominantly after symptoms become severe enough to disrupt daily life. India recorded an estimated 1.56 million new cancer cases and over 8,74,000 cancer deaths in 2024. While these technologies still require careful evaluation for population-wide implementation, they represent one of the most promising frontiers in cancer research and deserve focused Indian validation. The Draft National Health Research Policy 2026 provides an opportunity to accelerate this transformation. This approach should encourage innovation in affordable screening technologies, risk prediction models, digital health platforms, and implementation research that improves cancer detection across India’s diverse healthcare settings.